Printer Friendly

ORTHOMET, INC. RECEIVES FDA APPROVAL FOR EXTENSION TO KNEE PRODUCT LINE; BEGINS TRIAL DISTRIBUTION IN U.S. OF 3M SHOULDER PRODUCT

ORTHOMET, INC. RECEIVES FDA APPROVAL FOR EXTENSION TO KNEE PRODUCT LINE;
 BEGINS TRIAL DISTRIBUTION IN U.S. OF 3M SHOULDER PRODUCT
 MINNEAPOLIS, Dec. 2 /PRNewswire/ -- Orthomet, Inc. (NASDAQ: OMET) announced that it has received approval from the U.S. Food and Drug Administration (FDA) under Section 510(K) of the Food, Drug and Cosmetic Act for an A/P Curved Tibial Insert. This product expands the company's line of knee implant products and is designed to provide greater stability in total knee replacement procedures.
 The company also announced an agreement with 3M Health Care Ltd. to commence a trial distribution of 3M's Neer II Shoulder in the United States. B.J. Amdahl, Orthomet's president and chief operating officer, said, "We are enthusiastic about starting this test marketing and the prospect of working with 3M. The distribution of a shoulder product expands our current product offerings and yet keeps our design and manufacturing team focused on hips and knees."
 Initial orders are being placed under the trial agreement which is estimated to run about 90 days. At the conclusion of the trial period, the companies will determine whether to proceed with a final distribution agreement.
 Orthomet, Inc. is in the business of designing, manufacturing and marketing selected orthopedic products, primarily reconstructive knee and hip implants and related surgical instrumentation.
 -0- 12/2/91
 /CONTACT: James C. Hawley of Orthomet, 612-944-6112/
 (OMET) CO: Orthomet, Inc. ST: Minnesota IN: MTC SU:


KH -- MN017 -- 8530 12/02/91 17:29 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 2, 1991
Words:247
Previous Article:EXHIBITION OF KEITH HARING ART WORKS TO OPEN AS AIDS BENEFIT
Next Article:GULF SETS NOVEMBER DIVIDEND RATE FOR SERIES 1 PREFERENCE SHARES
Topics:


Related Articles
ORTHOMET, INC. ADDS DIRECTOR
ORTHOMET ADDS VICE PRESIDENT, SALES
ORTHOMET NAMES HAWLEY EXECUTIVE VICE PRESIDENT; ANNOUNCES FDA HAS APPROVED IMPORTANT KNEE IMPLANT PRODUCT FOR MARKETING
ORTHOMET RECEIVES FDA APPROVAL TO MARKET NEW HIP PRODUCTS
ORTHOMET OBTAINS LICENSE FROM MAYO FOR FINGER JOINT REPLACEMENT PRODUCT
ORTHOMET RECEIVES FDA APPROVAL TO MARKET ION IMPLANTED FEMORAL HEADS FOR TOTAL HIP REPLACEMENT
ORTHOMET SALES UP 40 PERCENT FOR FISCAL YEAR
ORTHOMET ENTERS FIVE-YEAR AGREEMENT TO DISTRIBUTE 3M RECONSTRUCTIVE SHOULDER PRODUCTS
FDA GRANTS ORTHOMET APPROVAL TO MARKET IMPORTANT ADDITIONS TO ITS KNEE PRODUCT LINE
ORTHOMET AND KIRSCHNER SIGN LETTER OF INTENT TO MERGE

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters